We assessed the distribution in brain pH after neonatal hypoxic-ischaemic insult and its correlation with local injury. Postnatal day 7 mice were injected with neutral red and underwent left carotid occlusion and exposure to 8% oxygen. Images captured from the cut surface of snap-frozen brain were used to calculate the pH from the blue-green absorbance ratios. Carotid occlusion alone had no effect, but combined with hypoxia caused rapid, biphasic pH decline, with the first plateau at 15–30 min, and the second at 60–90 min. The ipsilateral dorsal cortex, hippocampus, striatum and thalamus were most affected. Contralateral pH initially showed only 30% of the ipsilateral decline, becoming more acidotic with increasing duration. Systemic blood analysis revealed, compared with hypoxia alone, that combined insult caused a 63% decrease in blood glucose (1.3 ± 0.2 mM), a 2-fold increase in circulating lactate (17.7 ± 2.9 mM), a reduction in CO2 to 1.9 ± 0.1 kPa and a drop in pH (7.26 ± 0.06). Re-oxygenation resulted in the normalisation of systemic changes, as well as a global alkaline rebound in brain pH at 4–6 h. A topographic comparison of brain injury showed only a partial correlation with pH changes, with the severest injury occurring in the ipsilateral hippocampus and sparing acidic parts of the contralateral cortex.

Keywords:
Neonate, Neutral red, pH, Encephalopathy, Hypoxia-ischaemia
1.
Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P (2002): Molecular Biology of the Cell, ed 4. New York, Taylor & Francis, p 661, table 12-1.
2.
Brett CL, Donowitz M, Rao R (2005): Evolutionary origins of eukaryotic sodium/proton exchangers. Am J Cell Physiol 288:C223–239.
3.
Cady EB, Iwata O, Bainbridge A, Wyatt JS, Robertson NJ (2008): Phosphorus magnetic resonance spectroscopy 2 h after perinatal cerebral hypoxia-ischemia prognosticates outcome in the newborn piglet. J Neurochem 107:1027–1035.
4.
Chopp M, Chen H, Vande Linde AM, Brown E, Welch KM (1990a): Time course of postischemic intracellular alkalosis reflects the duration of ischemia. J Cereb Blood Flow Metab 10:860–865.
5.
Chopp M, Vande Linde AM, Chen H, Knight R, Helpern JA, Welch KM (1990b): Chronic cerebral intracellular alkalosis following forebrain ischemic insult in rats. Stroke 21:463–466.
6.
Crumrine RC, LaManna JC, Lust WD (1991): Regional changes in intracellular pH determined by neutral red histophotometry and high energy metabolites during cardiac arrest and following resuscitation in the rat. Metab Brain Dis 6:145–155.
7.
Giffard RG, Weiss JH, Choi DW (1992): Extracellular alkalinity exacerbates injury of cultured cortical neurons. Stroke 23:1817–1821.
8.
Goldman SA, Pulsinelli WA, Clarke WY, Kraig RP, Plum F (1989): The effects of extracellular acidosis on neurons and glia in vitro. J Cereb Blood Flow Metab 9:471–477.
9.
Hugg JW, Duijn JH, Matson GB, Maudsley AA, Tsuruda JS, Gelinas DF, Weiner MW (1992): Elevated lactate and alkalosis in chronic human brain infarction observed by 2C and 31P MR spectroscopic imaging. J Cereb Blood Flow Metab 12:734–744.
10.
Kendall GS, Robertson NJ, Iwata O, Peebles D, Raivich G (2006): N-methyl-isobutyl-amiloride ameliorates brain injury when commenced before hypoxia ischemia in neonatal mice. Pediatr Res 59:227–231.
11.
Khan JY, Rajakumar RA, McKnight RA, Devaskar UP, Devaskar SU (1999): Developmental regulation of genes mediating murine brain glucose uptake. Am J Physiol 276:R892–R900
12.
Kim M, Yu ZX, Fredholm BB, Rivkees SA (2005): Susceptibility of the developing brain to acute hypoglycemia involving A1 adenosine receptor activation. Am J Physiol Endocrinol Metab 289:E562–E569.
13.
Kintner DB, Wang Y, Sun D (2007): Role of membrane ion transport proteins in cerebral ischemic damage. Front Biosci 12:762–770.
14.
Kissel P, Chehrazi B, Seibert JA, Wagner FC Jr (1987): Digital angiographic quantification of blood flow dynamics in embolic stroke treated with tissue-type plasminogen activator. J Neurosurg 67:399–405.
15.
LaManna JC (1996): Hypoxia/ischemia and the pH paradox; in Ince C, Kesecioglu J, Telci L, Akpir K (eds): Oxygen Transport to Tissue XVII. New York, Plenum Press, pp 283–292.
16.
LaManna JC, McCracken KA (1984): The use of neutral red as an intracellular pH indicator in rat brain cortex in vivo. Anal Biochem 142:117–125.
17.
Levine SR, Helpern JA, Welch KM, Vande Linde AM, Sawaya KL, Brown EE, Ramadan NM, Deveshwar RK, Ordidge RJ (1992): Human focal cerebral ischaemia: evaluation of brain pH and energy metabolism with P-31 NMR spectroscopy. Radiology 185:537–544.
18.
Levine V, Pourcyrous M, Bada HS, Parfenova H, Yang WJ, Korones SB, Leffler CW (2000): Preservation of cerebrovascular tone and reactivity by sodium channel inhibition in experimental prolonged asphyxia in piglets. Pediatr Res 47:376–380.
19.
Lorek AY, Takei EB, Cady JS, Wyatt J, Penrice J, Edwards AD, Peebles DM, Wylezinska M, Owen-Rees H, Kirkbride V, Cooper C, Aldrige RF, Roth SC, Brown G, Delpy DT, Reynolds EOR (1994): Delayed (‘secondary’) cerebral energy failure following acute hypoxia-ischemia in the newborn piglet: continuous 48-hour studies by phosphorus magnetic resonance spectroscopy. Pediatr Res 36:699–706.
20.
Mabe H, Blomqvist P, Siesjo BK (1983): Intracellular pH in the brain following transient ischemia. J Cereb Blood Flow Metab 1:109–114.
21.
Maeda K, Hata R, Hossmann KA (1998): Differences in the cerebrovascular anatomy of C57black/6 and SV129 mice. Neuroreport 9:1317–1319.
22.
Mellgren RL (1987): Calcium dependent proteases: an enzyme system active at cellular membranes? FASEB J 1:110–115.
23.
Moller JC, Klein MA, Haas S, Jones LL, Kreutzberg GW, Raivich G (1996): Regulation of thrombospondin in the regenerating mouse facial motor nucleus. Glia 17:121–132.
24.
Obara M, Szeliga M, Albrecht J (2008): Regulation of pH in the mammalian central nervous system under normal and pathological conditions: facts and hypotheses. Neurochem Int 52:905–919.
25.
Palmer C, Brucklacher RM, Christensen MA, Vannucci RC (1990): Carbohydrate and energy metabolism during the evolution of hypoxic-ischemic brain damage in the immature rat. J Cereb Blood Flow Metab 10:227–235.
26.
Rice JE 3rd, Vannucci RC, Brierley JB (1981): The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 9:131–141.
27.
Robertson NJ, Cox IJ, Cowan FM, Counsell SJ, Azzopardi D, Edwards AD (1999): Cerebral intracellular lactic alkalosis persisting months after neonatal encephalopathy measured by magnetic resonance spectroscopy. Pediatr Res 46:287–296.
28.
Robertson NJ, Cowan FM, Cox IJ, Edwards AD (2002): Brain alkaline intracellular pH after neonatal encephalopathy. Ann Neurol 52:732–742.
29.
Sappey-Marinier D, Hubesch B, Matson GB, Weiner MW (1992): Decreased phosphorus metabolite concentrations and alkalosis in chronic cerebral infarction. Radiology 182:29–34.
30.
Selman WR, VanDerVeer C, Whittingham TS, LaManna JC, Lust WD, Ratcheson RA (1987): Visually defined zones of focal ischemia in the rat brain. Neurosurgery 21:825–830.
31.
Siesjö BK, Folbergrová J, MacMillan V (1972): The effect of hypercapnia upon intracellular pH in the brain, evaluated by the bicarbonate-carbonic acid method and from the creatine phosphokinase equilibrium. J Neurochem 19:2483–2495.
32.
Silverstein F, Buchanan K, Johnston MV (1984): Pathogenesis of hypoxic-ischemic brain injury in a perinatal rodent model. Neurosci Lett 31:271–277.
33.
Simon RP, Niro M, Gwinn R (1993): Brain acidosis induced by hypercarbic ventilation attenuates focal ischemic injury. J Pharmacol Exp Ther 267:1428–1431.
34.
Sousa C, Sá e Melo T, Gèze M, Gaullier JM, Mazière JC, Santus R (1996): Solvent polarity and pH effects on the spectroscopic properties of neutral red: application to lysosomal microenvironment probing in living cells. Photochem Photobiol 63:601–607.
35.
Towfighi J, Housman C, Vannucci RC, Heitjan DF (1994): Effect of unilateral perinatal hypoxic-ischemic brain damage on the gross development of opposite cerebral hemisphere. Biol Neonate 65:108–118.
36.
Traynelis S, Cull-Candy S (1990): Proton inhibition of NMDA receptors in cerebellar neurons. Nature 356:347–349.
37.
Tuor UI, Simone CS, Barks JD, Post M (1993): Dexamethasone prevents cerebral infarction without affecting cerebral blood flow in neonatal rats. Stroke 24:452–457.
38.
Vannucci RC, Brucklacher RM, Vannucci SJ (1996): The effect of hyperglycemia on cerebral metabolism during hypoxia-ischemia in the immature rat. J Cereb Blood Flow Metab 16:1026–1033.
39.
Vannucci RC, Brucklacher RM, Vannucci SJ (2005): Glycolysis and perinatal hypoxic-ischemic brain damage. Dev Neurosci 2005 27:185–190.
40.
Vannucci RC, Towfighi J, Brucklacher RM, Vannucci SJ (2001): Effect of extreme hypercapnia on hypoxic-ischemic brain damage in the immature rat. Pediatr Res 49:799–803.
41.
Vannucci RC, Vannucci SJ (2005): Perinatal hypoxic-ischemic brain damage: evolution of an animal model. Dev Neurosci 27:81–86.
42.
Vannucci SJ, Simpson IA (2003): Developmental switch in brain nutrient transporter expression in the rat. Am J Physiol Endocrinol Metab 285:E1127–E1134.
43.
Vannucci SJ, Vannucci RC (1998): Brain metabolism in the fetus and neonate; in Cowett RM (ed): Principles of Perinatal-Neonatal Metabolism. New York, Springer, pp 537–550.
44.
Welch KM, Levine SR, Helpern JA (1990): Pathophysiological correlates of cerebral ischemia the significance of cellular acid base shifts. Funct Neurol 5:21–31.
45.
Yager JY, Brucklacher RM, Vannucci RC (1991): Cerebral oxidative metabolism and redox state during hypoxia-ischemia and early recovery in immature rats. Am J Physiol 261:H1102–H1108.
46.
Zhang Z, Chopp M, Zhang RL, Goussev A (1997): A mouse model of embolic focal cerebral ischemia. J Cereb Blood Flow Metab 17:1081–1088.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.